Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Transcept Pharma Promotes CFO Thomas Soloway To COO

Transcept Pharmaceuticals (TSPT: Quote) said Tuesday that it has appointed Thomas Soloway as the executive vice president and chief operating officer. Soloway joined Transcept as a co-founder in 2002 and served previously as Senior Vice President, Operations and Chief Financial Officer prior to this promotion.

All senior executives of the company, except Chief Scientific Officer and Co-Founder Nikhilesh Singh, will hereafter report to Soloway. Singh will continue to report to President and Chief Executive Officer Glenn Oclassen.

Click here to receive FREE breaking news email alerts for Transcept Pharmaceuticals, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks are turning in a lackluster performance in early trading on Wednesday after moving sharply higher over the past few sessions. The major averages have been bouncing back and forth across the unchanged line, unable to sustain any significant moves. Consumer prices in the U.S. unexpectedly showed a modest increase in the month of September, according to a report released by the Labor Department on Wednesday, with higher prices for food and shelter offsetting a continued decline in energy prices. The European Parliament has given its strong support to the new European Commission with 423 votes in favor, 209 against and 67 abstentions. The approval was crucial for the Juncker Commission to start a five-year term on 1 November. Today's vote marks the last step in the process leading up to the new European Commission. The European Cabinet has a representative each from all 28 EU member states
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.